Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Frank Kung. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Frank Kung zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:AMRS / Amyris Inc | Director | 0 |
| US:SGNT / Sagent Pharmaceuticals, Inc. | Director | 921 |
| 10% Owner | 945 200 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Frank Kung. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Frank Kung ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-07 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -16 207 | 0 | -100,00 | ||||
| 2024-05-07 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -938 416 | 0 | -100,00 | ||||
| 2024-05-07 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -6 796 205 | 0 | -100,00 | ||||
| 2022-09-23 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -36 488 | 0 | -100,00 | 3,50 | -127 708 | |
| 2022-09-23 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -163 512 | 0 | -100,00 | 3,50 | -572 292 | |
| 2022-09-23 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -72 972 | 36 488 | -66,67 | 3,60 | -262 699 | 131 357 |
| 2022-09-23 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -327 028 | 163 512 | -66,67 | 3,60 | -1 177 301 | 588 643 |
| 2022-09-22 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -36 488 | 0 | -100,00 | 3,50 | -127 708 | |
| 2022-09-22 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -163 512 | 0 | -100,00 | 3,50 | -572 292 | |
| 2022-09-22 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -72 972 | 36 488 | -66,67 | 3,60 | -262 699 | 131 357 |
| 2022-09-22 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -327 028 | 163 512 | -66,67 | 3,60 | -1 177 301 | 588 643 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -197 148 | 109 460 | -64,30 | 3,80 | -749 162 | 415 948 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -883 528 | 490 540 | -64,30 | 3,80 | -3 357 406 | 1 864 052 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -151 983 | 306 608 | -33,14 | 3,60 | -547 139 | 1 103 789 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -681 117 | 1 374 068 | -33,14 | 3,60 | -2 452 021 | 4 946 645 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -252 667 | 458 591 | -35,52 | 4,20 | -1 061 201 | 1 926 082 |
| 2022-09-19 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | X | -1 132 333 | 2 055 185 | -35,52 | 4,20 | -4 755 799 | 8 631 777 |
| 2022-08-29 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 7 409 | 16 207 | 84,21 | ||||
| 2022-08-29 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -7 409 | 80 000 | -8,48 | ||||
| 2022-08-29 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 80 000 | 87 409 | 1 079,77 | ||||
| 2022-08-24 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 80 000 | 80 000 | |||||
| 2021-08-26 |
|
4/A | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 7 409 | 7 409 | |||||
| 2021-08-25 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 7 409 | 7 409 | |||||
| 2021-08-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 2 266 | 8 798 | 34,69 | ||||
| 2021-08-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -2 266 | 0 | -100,00 | ||||
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -147 111 | 0 | -100,00 | 4,76 | -700 248 | ||
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -1 065 676 | 0 | -100,00 | 4,76 | -5 072 618 | ||
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 147 111 | 938 416 | 18,59 | 4,76 | 700 248 | 4 466 860 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 1 065 676 | 6 796 205 | 18,60 | 4,76 | 5 072 618 | 32 349 936 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -1 005 | 0 | -100,00 | ||||
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -7 275 | 0 | -100,00 | ||||
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -286 032 | 711 258 | -28,68 | 14,96 | -4 279 754 | 10 642 198 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -1 281 858 | 3 187 518 | -28,68 | 14,96 | -19 179 800 | 47 693 238 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -377 384 | 791 305 | -32,29 | 14,96 | -5 646 608 | 11 839 901 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -2 733 089 | 5 730 529 | -32,29 | 14,96 | -40 893 844 | 85 743 040 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 235 829 | 1 168 689 | 25,28 | 4,26 | 1 004 632 | 4 978 615 | |
| 2021-04-15 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 1 707 830 | 8 463 618 | 25,28 | 4,26 | 7 275 356 | 36 055 013 | |
| 2020-11-04 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 666 | 6 532 | 11,35 | ||||
| 2020-11-04 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -666 | 2 266 | -22,71 | ||||
| 2020-10-27 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 2 266 | 5 866 | 62,94 | ||||
| 2020-10-27 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -2 266 | 2 932 | -43,59 | ||||
| 2020-08-07 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 3 466 | 3 466 | |||||
| 2020-08-07 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 2 266 | 5 198 | 77,29 | ||||
| 2020-08-07 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 3 466 | 3 466 | |||||
| 2020-08-07 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 2 266 | 5 198 | 77,29 | ||||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Series E Convertible Preferred Stock |
P - Purchase | 195 | 195 | 1 000,00 | 195 082 | 195 082 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Series E Convertible Preferred Stock |
P - Purchase | 1 336 | 1 336 | 1 000,00 | 1 336 216 | 1 336 216 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Series E Convertible Preferred Stock |
P - Purchase | 1 413 | 1 413 | 1 000,00 | 1 412 736 | 1 412 736 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Series E Convertible Preferred Stock |
P - Purchase | 5 988 | 5 988 | 1 000,00 | 5 988 286 | 5 988 286 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 551 884 | 551 884 | 3,00 | 1 655 652 | 1 655 652 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 80 573 | 867 832 | 10,23 | 3,00 | 241 719 | 2 603 496 | |
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 2 473 280 | 2 473 280 | 3,00 | 7 419 840 | 7 419 840 | ||
| 2020-06-09 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 583 488 | 6 284 876 | 10,23 | 3,00 | 1 750 464 | 18 854 628 | |
| 2019-11-05 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 667 | 3 600 | 22,74 | ||||
| 2019-11-05 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -667 | 2 932 | -18,53 | ||||
| 2019-10-25 |
|
4 | AMRS |
AMYRIS, INC.
Stock Option (Right to Buy) |
A - Award | 3 466 | 3 466 | |||||
| 2019-10-25 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 2 266 | 3 599 | 169,99 | ||||
| 2019-08-05 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 2 266 | 2 933 | 339,73 | ||||
| 2019-08-05 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -2 266 | 1 333 | -62,96 | ||||
| 2019-05-01 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
P - Purchase | 147 111 | 147 111 | 0,12 | 18 389 | 18 389 | ||
| 2019-05-01 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
P - Purchase | 1 065 676 | 1 065 676 | 0,12 | 133 210 | 133 210 | ||
| 2019-05-01 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 110 811 | 787 259 | 16,38 | 4,76 | 527 460 | 3 747 353 | |
| 2019-05-01 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
P - Purchase | 802 718 | 5 701 388 | 16,39 | 4,76 | 3 820 938 | 27 138 607 | |
| 2018-11-02 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | 667 | 667 | |||||
| 2018-11-02 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
J - Other | -667 | 3 599 | -15,64 | ||||
| 2018-08-24 |
|
4/A | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 256 251 | 256 251 | |||||
| 2018-08-24 |
|
4/A | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 1 855 706 | 1 855 706 | |||||
| 2018-08-24 |
|
4/A | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 619 749 | 619 749 | |||||
| 2018-08-24 |
|
4/A | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 4 488 072 | 4 488 072 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 256 251 | 256 251 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 1 855 706 | 1 855 706 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -197 877 | 0 | -100,00 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -1 432 977 | 0 | -100,00 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 197 877 | 676 448 | 41,35 | 4,40 | 870 659 | 2 976 371 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 1 432 977 | 4 898 670 | 41,35 | 4,40 | 6 305 099 | 21 554 148 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -139 306 | 478 571 | -22,55 | 6,22 | -866 316 | 2 976 137 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -1 008 816 | 3 465 693 | -22,55 | 6,22 | -6 273 625 | 21 552 452 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 619 749 | 619 749 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
A - Award | 4 488 072 | 4 488 072 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
D - Sale to Issuer | 0 | 0 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
D - Sale to Issuer | 0 | 0 | |||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -478 571 | 197 877 | -70,75 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Warrant (Right to Buy) |
M - Exercise | -3 465 693 | 1 432 977 | -70,75 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Series D Convertible Preferred Stock |
M - Exercise | -568 | 1 005 | -36,10 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Series D Convertible Preferred Stock |
M - Exercise | -4 111 | 7 275 | -36,10 | ||||
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 478 571 | 617 877 | 343,54 | 4,40 | 2 105 712 | 2 718 659 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 3 465 693 | 4 474 509 | 343,54 | 4,40 | 15 249 049 | 19 687 840 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -336 914 | 139 306 | -70,75 | 6,22 | -2 095 201 | 866 316 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
S - Sale | -2 439 848 | 1 008 816 | -70,75 | 6,22 | -15 172 927 | 6 273 625 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 133 246 | 476 220 | 38,85 | 4,26 | 567 628 | 2 028 697 | |
| 2018-08-21 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
M - Exercise | 964 927 | 3 448 664 | 38,85 | 4,26 | 4 110 589 | 14 691 309 | |
| 2018-08-03 |
|
4 | AMRS |
AMYRIS, INC.
Stock Option (Right to Buy) |
A - Award | 3 466 | 3 466 | |||||
| 2018-08-03 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 2 266 | 4 266 | 113,30 | ||||
| 2017-11-08 |
|
4 | AMRS |
AMYRIS, INC.
Stock Option (Right to Buy) |
A - Award | 3 000 | 3 000 | |||||
| 2017-11-08 |
|
4 | AMRS |
AMYRIS, INC.
Common Stock |
A - Award | 2 000 | 2 000 | |||||
| 2017-11-08 | 3 | AMRS |
AMYRIS, INC.
Common Stock |
5 310 448 | ||||||||
| 2017-11-08 | 3 | AMRS |
AMYRIS, INC.
Common Stock |
3 169 685 | ||||||||
| 2017-11-08 | 3 | AMRS |
AMYRIS, INC.
Common Stock |
5 310 448 | ||||||||
| 2017-11-08 | 3 | AMRS |
AMYRIS, INC.
Common Stock |
3 169 685 | ||||||||
| 2015-04-13 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
A - Award | 921 | 921 | |||||
| 2015-02-27 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
A - Award | 1 841 | 1 841 | |||||
| 2015-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -567 | 567 | -50,00 | ||||
| 2015-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 567 | 36 909 | 1,56 | ||||
| 2015-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -760 | 1 520 | -33,33 | ||||
| 2015-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 760 | 36 342 | 2,14 | ||||
| 2015-02-20 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -930 | 2 790 | -25,00 | ||||
| 2015-02-20 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 930 | 35 582 | 2,68 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 6 870 | 945 200 | 0,73 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 6 870 | 945 200 | 0,73 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 585 437 | 938 330 | 165,90 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 585 437 | 938 330 | 165,90 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 4 093 | 352 893 | 1,17 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 4 093 | 352 893 | 1,17 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 348 800 | 348 800 | |||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 348 800 | 348 800 | |||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 17 | 331 111 | 0,01 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 1 002 | 331 094 | 0,30 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 4 205 | 330 092 | 1,29 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 3 778 | 325 887 | 1,17 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 322 109 | 322 109 | |||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Preferred Stock |
C - Conversion | -31 250 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Preferred Stock |
C - Conversion | -1 755 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Preferred Stock |
C - Conversion | -95 112 | 1 755 | -98,19 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Preferred Stock |
C - Conversion | -19 766 | 96 867 | -16,95 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -1 102 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -59 638 | 1 102 | -98,19 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -178 408 | 64 740 | -73,37 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -240 | 239 148 | -0,10 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -137 277 | 239 388 | -36,45 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -18 401 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -1 567 879 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -596 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -32 569 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -136 441 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -110 642 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -9 427 595 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 6 870 | 3 497 288 | 0,20 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 585 437 | 3 490 418 | 20,15 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 4 093 | 2 904 981 | 0,14 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 348 800 | 2 900 888 | 13,67 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 122 | 2 552 088 | 0,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 6 689 | 2 551 966 | 0,26 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 28 028 | 2 545 277 | 1,11 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 22 729 | 2 517 249 | 0,91 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 1 936 843 | 2 494 520 | 347,31 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 31 250 | 557 677 | 5,94 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 1 755 | 526 427 | 0,33 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 95 112 | 524 672 | 22,14 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 19 766 | 429 560 | 4,82 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 1 102 | 409 794 | 0,27 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 59 638 | 408 692 | 17,09 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 178 408 | 349 054 | 104,55 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 1 611 | 170 646 | 0,95 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 137 277 | 169 035 | 432,26 | ||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
52 390 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 486 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
37 059 | ||||||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
Common Stock |
31 855 | ||||||||
| 2014-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -567 | 1 134 | -33,33 | ||||
| 2014-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 567 | 34 652 | 1,66 | ||||
| 2014-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -759 | 2 280 | -24,98 | ||||
| 2014-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 759 | 34 085 | 2,28 | ||||
| 2014-02-19 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
A - Award | 3 720 | 3 720 | |||||
| 2013-09-17 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
S - Sale | -622 700 | 4 180 791 | -12,96 | 21,25 | -13 232 375 | 88 841 809 | |
| 2013-09-17 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
S - Sale | -539 017 | 3 618 946 | -12,96 | 21,25 | -11 454 111 | 76 902 602 | |
| 2013-02-25 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
M - Exercise | -567 | 1 701 | -25,00 | ||||
| 2013-02-25 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 567 | 33 326 | 1,73 | ||||
| 2013-02-25 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
A - Award | 3 039 | 3 039 | |||||
| 2012-06-04 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock |
M - Exercise | -3 190 | 0 | -100,00 | ||||
| 2012-06-04 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 3 190 | 32 759 | 10,79 | 4,23 | 13 494 | 138 571 | |
| 2012-04-19 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock |
M - Exercise | -3 190 | 3 189 | -50,01 | ||||
| 2012-04-19 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 3 190 | 29 569 | 12,09 | 4,23 | 13 494 | 125 077 | |
| 2012-02-24 |
|
4 | SGNT |
Sagent Pharmaceuticals, Inc.
Restricted Stock Units |
A - Award | 2 268 | 2 268 |